Aptar Q1 EPS $1.23 ($1.26 adj) up 50% (31% adj); revenue $915M +6%

APTARGROUP, INC.

2024-Q1 EPS reported $1.23 revenue$915,448,000

Reported net income $83M (+52%); adjusted EBITDA $179M (+16%).
Pharma core sales +13% driven by proprietary drug delivery systems; Beauty core -1%, Closures core +1%.
Q2 2024 adjusted EPS guidance $1.30-$1.38; tax rate 22-24%.
Quarterly dividend of $0.41/share payable May 16 to holders of record April 25; $12M in share repurchases.
Lower tax rate of 20.6% vs 25.6% prior year contributed $0.07 EPS benefit.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.98

APTARGROUP, INC. reported the quarter ended March 31, 2024 results: revenue $915 million, net income $83 million, EPS $1.23. Guidance reaffirmed.

Period: the quarter ended March 31, 2024
Revenue: $915 million
Net income: $83 million
EPS: $1.23
Guidance: reaffirmed
Result: reported results

Exact text from the filing

year quarter, driven by improved operational performance and cost management efforts First Quarter Results For the quarter ended March 31, 2024, reported sales increased 6% to $915 million compared to $860 million in the prior year. Core sales, excluding the impact from changes in currency exchange rates and acquisitions, increased 5%. First Quarter Segment Sales

View on SEC.gov

364 earnings releases filed in the last 30 days. Browse all earnings releases →

APTARGROUP, INC. filing history →

Source: SEC EDGAR

accession 0000896622-24-000018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.